X-Nico

2 unusual facts about Paul Ehrlich


Heribert Offermanns

Offermanns was board member of the Paul Ehrlich Foundation and chairman of the board of trustees of the Max-Planck-Institute for Solid State Research, Stuttgart.

Kurloff cells

Paul Ehrlich, German scientist in the fields of hematology, immunology, and chemotherapy


African trypanosomiasis

The first effective treatment, atoxyl, an arsenic-based drug developed by Paul Ehrlich and Kiyoshi Shiga, was introduced in 1910, but blindness was a serious side effect.

Friedrich Theodor von Frerichs

Some of his better known assistants and students included Paul Ehrlich (1854–1915), Adolf Weil (1848–1916), Paul Langerhans (1847–1888), Bernhard Naunyn (1839–1925), Heinrich Irenaeus Quincke (1842–1922), Friedrich Albin Hoffmann (1843-1924), Wilhelm Ebstein (1836–1912) and Hugo Rühle (1824–1888).

Metachromasy

Although metachromasy was observed and described since 1875, by Cornil, Ranvier and others, it was the German scientist Paul Ehrlich (1854-1915) who gave its name and studied it more extensively.

Neosalvarsan

Both salvarsan and neosalvarsan were developed in the laboratory of Paul Ehrlich in Frankfurt, Germany.

Niels Kaj Jerne

Jerne developed the "natural selection theory of immunology," proposed by Paul Ehrlich 50 years earlier, although he was missing the clonal selection element proposed by David Talmage and then by Frank Macfarlane Burnet.

Prodrug

The first synthetic antimicrobial drug, arsphenamine, discovered in 1909 by Sahachiro Hata in the laboratory of Paul Ehrlich, is not toxic to bacteria until it has been converted to an active form by the body.


see also

LuEsther Mertz

In 1980, Dennis Murphy and Paul Ehrlich of the Center for Conservation Biology named a subspecies of the Edith's Checkerspot butterfly, Euphydryas editha luestherae, in her honor.